Portosystemic shunts in dogs and cats

Moore, Alasdair Hotston
October 2011
Veterinary Ireland Journal;Oct2011, Vol. 1 Issue 10, p560
Academic Journal
Portosystemic shunts ('liver shunts', PSS) are an important and relatively frequent disease of dogs and cats. Anatomically, a PSS is one or more venous connections between the portal vein and the systemic venous system, typically the caudal vena cava or azygous vein. Most PSS are macroscopic venous structures but in some breeds abnormalities of the microcirculation within the liver results in functional shunting without macroscopic vascular abnormalities (microvascular dysplasia, MVD). Clinical signs are often somewhat non-specific (unthriftiness, vomiting, anorexia) and also typically include either neurological abnormalities (hepatic encephalopathy) or urinary obstruction (urate urolithiasis). Shunts can be classified as congenital or acquired. Acquired shunts are a feature of chronic liver disease and secondary portal hypertension and are of little surgical interest. Affected animals are treated for the effects of hepatic encephalopathy and for the underlying liver disease if possible. These are not the focus of this article. Animals with congenital shunts can be managed with medical treatments and dietary manipulation to reduce the signs of hepatic encephalopathy and in the majority there is a good or excellent short to medium term improvement in clinical signs. However, if surgical occlusion of the shunt is possible, the long term outcome is improved compared to those managed medically alone. For most animals, therefore, it is logical to recommend surgical intervention following a period of medical stabilisation. PSS are seen in dogs and cats. In dogs, breed dispositions to both congenital macroscopic PSS and to MVD are reported.


Related Articles

  • More answers needed on congenital portosystemic shunts in dogs and cats. Philbey, Adrian W. // Veterinary Record: Journal of the British Veterinary Association;4/6/2013, Vol. 172 Issue 14, p360 

    An introduction for the articles published in the periodical is presented which incorporates the topic intrahepatic congenital portosystemic shunts (CPSS) in animals.

  • Surgical management of urethral obstruction in dogs and cats. Moore, Alasdair Hotston; Lodge, Rosemary // Veterinary Ireland Journal;Jun2011, Vol. 64 Issue 6, p330 

    Urethral obstruction is a relatively common presentation in dogs and cats. The relatively long and narrow urethra of the male results in the presentation being more common in this sex, although cases also occur in bitches and queens. Obstruction by uroliths (including sludge and mucus plugs) is...

  • Selected highlights from other journals.  // Veterinary Record: Journal of the British Veterinary Association;6/8/2013, Vol. 172 Issue 23, p615 

    The article presents abstracts on the detection of risk factors for postoperative pyothorax in dogs, the evaluation of flexion tests in horses and the underlying disease mechanism for feline degenerative joint disease (DID) that are not caused by aging.

  • NOT TOO OLD FOR SURGERY.  // Whole Dog Journal;Oct2012, Vol. 15 Issue 10, p10 

    This article describes two cases of lipoma surgery performed on old dogs.

  • Urinary capillariosis in a cat in the UK. Whitehead, Martin // Veterinary Record: Journal of the British Veterinary Association;12/19/2009, Vol. 165 Issue 25, p757 

    The article provides information about the Capillaria (pearsonema) plica among cats and dogs. It states that the disease is a common parasite of the urinary system of wild canids and mustelids with a worldwide distribution. The disease can be treated with 0.2 milligrams/kilograms doramectin...

  • Portosystemic shunts in dogs: Can medical therapy allow a delay in surgical intervention?  // Veterinary Medicine;Mar2011, Vol. 106 Issue 3, p114 

    The article offers information on a veterinary medical research related to the effectiveness of medical therapy in surgical intervention for inserting portosystemic shunts in dogs. The findings suggested that surgical intervention can delay medical therapy in some dogs. It was also seen that in...

  • Precipitation of hepatic encephalopathy propranolol in cirrhosis. Tarver, D.; Walt, R.P.; Dunk, A.A.; Jenkins, W.J.; Sherlock, S. // British Medical Journal (Clinical Research Edition);8/27/1983, Vol. 287 Issue 6392, p585 

    Reports a case of a patient treated with propranolol for the prevention of recurrent variceal bleeding precipitated hepatic encephalopathy. Assessment of liver dysfunction; Occurrence of gastrointestinal hemorrhage; Stability of liver function tests.

  • Metronidazole.  // Reactions Weekly;7/10/2010, Issue 1309, p29 

    The article describes the case of a patient who died from encephalopathy after administration of intravenous metronidazole.

  • Rifaximin prevents recurrent hepatic encephalopathy.  // JAAPA: Journal of the American Academy of Physician Assistants (;Jun2010, Vol. 23 Issue 6, p54 

    The article reports on a study which found that using daily rifaximin reduces the risk of breakthrough episodes of hepatic encephalopathy (HE) and HE-related hospitalizations in patients with chronic liver disease and recurrent HE.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics